Comparing RxSight (NASDAQ:RXST) and Echo Therapeutics (OTCMKTS:ECTE)

RxSight (NASDAQ:RXST) and Echo Therapeutics (OTCMKTS:ECTE) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, valuation and institutional ownership.

Profitability

This table compares RxSight and Echo Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
RxSight	-21.93%	-11.56%	-10.31%
Echo Therapeutics	N/A	N/A	N/A

Earnings and Valuation

This table compares RxSight and Echo Therapeutics”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RxSight	$139.93 million	2.20	-$27.45 million	($0.80)	-9.39
Echo Therapeutics	N/A	N/A	N/A	N/A	N/A

Echo Therapeutics has lower revenue, but higher earnings than RxSight.

Analyst Recommendations

This is a summary of recent ratings for RxSight and Echo Therapeutics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RxSight	3	9	1	0	1.85
Echo Therapeutics	0	0	0	0	0.00

RxSight currently has a consensus target price of $10.00, suggesting a potential upside of 33.16%. Given RxSight’s stronger consensus rating and higher probable upside, analysts plainly believe RxSight is more favorable than Echo Therapeutics.

Insider & Institutional Ownership

78.8% of RxSight shares are held by institutional investors. 9.6% of RxSight shares are held by company insiders. Comparatively, 7.0% of Echo Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

RxSight beats Echo Therapeutics on 6 of the 9 factors compared between the two stocks.

About RxSight

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

About Echo Therapeutics

Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.